More reporting from Cannabis Professional
CannTrust Holdings Inc. has thousands of cannabis plants behind temporary walls in order to stage misleading photographs of an unlicensed growing room sent to Health Canada, a former CannTrust employee alleges
The Vaughan, Ont-based cannabis producer is under investigation by Health Canada after federal regulators found CannTrust was growing cannabis in five unlicensed rooms in its greenhouse in Pelham, Ont., between October, 201
8, and March, the company acknowledged Monday. The announcement sent CannTrust's NYSE-listed stock more than 35 per cent since Monday.
According to Nick Lalonde, who worked for the company from June, 2017, to May, 2019, and served as head of disposal operations at the Pelham greenhouse, Cann explicitly took steps to hide its unlicensed operations from Health Canada
Story continues below advertisement
At at least one occasion last fall, employees were asked to stay late to make up fake walls to hide "several thousand" plants from view, in order to take photographs that had been ordered by Health Canada as part of routine licensing requirements, Mr. Lalonde told The Globe and Mail
On Monday, confirmed that Health Canada issued a non-compliance order to the company and put a sales freeze on 5,200 kilograms of product that had been grown in the five unlicensed rooms between October and March ; the five rooms were subsequently licensed in April.
The company said it was also voluntarily holding back from sale an additional 7,500 kg of product that was grown in the unlicensed rooms in the same time period.
Health Canada's continuing investigation has raised questions among analysts about whether federal regulators could take the step of suspending CannTrust's license. In the last year, federal regulators have suspended the licenses of cannabis companies for illegal activities.
CannTrust acknowledged on Monday that employees had provided "inaccurate information" to regulators.
Mr. Lalonde said the order to stage the misleading photographs came from a greenhouse operations manager; he said it does not know whether or not the order came from higher up the management chain. Mr. Lalonde said he directly participated in staging one misleading photograph last fall
picture of the room with nothing in it, "Mr. Lalonde said
Story continues below advertisement
Story continues below advertisement
"Health Canada requested pictures of the ranges [greenhouse rooms] in order to give the license and the permit; they wanted to see pictures of the range complete and functioning correctly with no plants in it, because it's not licensed room at the time, "Mr. Lalonde said.
On June 14, shortly after meeting CannTrust for a job outside the cannabis industry, Mr. Lalonde sent and e-mail – reviewed this week by The Globe – to Health Canada officials outlining the activity that took place at the company.
requested you to see us hanging up white poly walls to cover up thousands of plants, ”Mr. Lalonde wrote to Health Canada
Two days later, Health Canada visited CannTrust's facility, conducted interviews with employees and requested documentation from the company. On July 3, Health Canada issued its non-compliance order.
"CannTrust has acknowledged the findings of Health Canada's report, which are focused on two key issues that Health Canada identified and that we are taking very seriously – the first is that we were growing in unlicensed rooms and the second group of observances involve employees who provided inaccurate information to health Canada inspectors, ”the company said in an e-mailed response to questions from The Globe.
" As examples, some of these instances revolved around information that was provided about the unlicensed growing rooms, as well as our documentation practices. We are very observant, and we are working closely with Health Canada and our internal teams to implement new processes and a company-wide retraining program
Story continues below advertisement
"As CannTrust announced earlier this week, we also have our full response to Health Canada rega rding specific details and responsibility. That is the road back to compliance. Until that time, "the company wrote
A company spokesperson said CEO Peter Aceto was unavailable for an interview on Wednesday. The company also declined to answer to a question about whether or not. Aceto and other top management knew that plants were growing in the unlicensed rooms
In an interview with The Globe on Monday, Mr. Aceto declined to say what, if anything, he or other upper management knew about the growing activity in the unlicensed rooms, saying only that CannTrust was "doing a root cause analysis to figure out who knew what when," and that one unnamed employee had been terminated.
On the company's most recent earnings call in May, Mr. Aceto, the former CEO of Tangerine Bank who joined CannTrust in October, tapped the company's significant quarter-over-quarter increase in production.
“Firstly, with respect to increasing production capacity, CannTrust delivered a record or over 9,400 kilograms of production in the first quarter from our perpetual harvest greenhouse. This is a 96-percent increase over Q4 2018. This increased production is the result of our investment into people, training and facilities, "Mr. Aceto said on the call
The fallout from Monday's announcement about the non-compliance order and the sales freeze has been dramatic, especially for the company that was widely seen as one of the more sophisticated operators in the industry.
Story continues below advertisement
On Wednesday, the Ontario Cannabis Store (OCS), the province's wholesalers and online retailer, decided to temporarily stop selling CannTrust products.
“Due to the Health Canada temporary hold on certain CannTrust cannabis products, OCS has removed all affected products from distribution pending the outcome of the investigation, "OCS communications director Daffyd Roderick said in a statement.
The Alberta Gaming, Liquor and Cannabis Commission also announced Wednesday that it" is placing the affected [CannTrust] Lots on hold while Health Canada conducts its investigation. ”
Royal Bank of Canada analyst Douglas Miehm slashed his CannTrust p rice target from $ 13 to $ 5, while Bank of Montreal analyst Tamy Chen cut her target from $ 11 to $ 6. Bank of America analyst Christopher Carey downgraded the stock of notches from "buy" to "underperform" and dropped his price target from $ 9 to $ 4.50.
While it conducts its investigation – which is expected to end on July 17 – Health Canada is allowing CannTrust to continue production in its two Ontario facilities, including in the five rooms at the heart of non-compliance order.